FDLI SmartBrief Latest Industry News

Latest News

Humana bike program picks up parks partner | courier-journal | The Courier-Journal

Courier-Journal (Louisville, Ky.), The | 23 minutes ago

Humana is extending its bicycle-sharing initiative to the National Park Service.... (more)

Business brief :: CHICAGO SUN-TIMES :: Business

December job cuts most since 1993 Employers announced 166,348 job cuts nationally in December, the largest December number since outplacement firm Challenger Gray & Christmas began tracking such data in 1993, the company said in releasing a monthly report Wednesday that showed Illinois-based workers faring better. The cuts nationally in December were nearly four times larger than a year earlier, when employers announced 44,416 job cuts. There were 2,759 job cuts announced by Illinois-ba...... (more)

PPD enters into strategic collaboration with Merck

Pharmabiz.com (India) | 59 minutes ago

PPD, Inc has entered into a strategic collaboration with Merck & Co, Inc, involving vaccine testing and assay development. Under the agreements, PPD purchased Merck's 130,000 square-foot vaccine testing laboratory and related equipment in Wayne, Pennsylvania, and hired the nearly 80 Merck professionals who operate this state-of-the-art facility. As part of this collaboration, PPD will be providing Merck with assay development and immunogenicity testing services to support Merck's vaccine port...... (more)

Anacor raises $50 investments from GSK, Schering Corp & investors

Pharmabiz.com (India) | 59 minutes ago

Anacor Pharmaceuticals announced that it has raised $50 million through a preferred stock financing with participation from GlaxoSmithKline (GSK), Schering Corporation and existing investors including Rho Capital Partners, Venrock Associates, Care Capital and Aberdare Ventures. Proceeds from the financing will be used to further develop Anacor's product pipeline based on its boron chemistry platform.... (more)

Cloud Computing Looms Larger on Corporate Horizon

NewsFactor Network | 1 hour 3 minutes ago

For all the potential and hype surrounding cloud computing, breaking old habits won't be easy -- particularly with business-software powerhouses Microsoft, IBM Corp., Oracle Corp. and SAP AG all maneuvering to protect their existing, lucrative software franchises while also setting up their own online services to compete with the industry upstarts. ... (more)

Sun Rises In U.S. Generic Market - Forbes.com

Forbes | 2 hours 56 minutes ago

India's Sun Pharmaceuticals has joined the ranks of the oversaturated pain management market in the United States, gaining approval for a generic version of Vicodin.This is the Indian company's first U.S. Food and Drug Administration approval for the marketing of a generic version of a controlled substance. During the holiday season, it also gained approval for three other generic drugs: cholesterol-fighting Lopid, high blood calcium treatment Aredia and anti-allergent Phenargen.... (more)

Nursing homes face Medicaid cuts | floridatoday.com | FLORIDA TODAY

Florida Today (Melbourne) | 2 hours 57 minutes ago

TALLAHASSEE -- For the 79,000 Floridians who live in a nursing home, life is going to get worse, according to advocates who warned Tuesday that the Florida Legislature is going too far in its rush to close a $2.4 billion budget gap.... (more)

Digest

Houston Chronicle | 3 hours 5 minutes ago

Citgo Chairman, President and CEO Alejandro Granado.... (more)

Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals - Press Releases: PR Newswire: Utilities - SunHerald.com

Sun Herald (Biloxi-Gulfport, Miss.), The | 3 hours 46 minutes ago

SEATTLE, Jan. 8 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that they received $7.5 million pursuant to the joint venture transaction with Spectrum Pharmaceuticals, Inc. to commercialize and develop Zevalin(R) in the United States. In December, the Company received the initial $7.5 million payment in connection with the closing of such transaction. The Company may earn up to an additional $15 million in product sales milestone payme...... (more)

Major lab discloses problem with vitamin D testing

San Francisco Chronicle | 6 hours 20 minutes ago

You must be signed in to add a comment. Sign In | Register... (more)

Endo Pharma to acquire Indevus Pharma

Pharmabiz.com (India) | 6 hours 25 minutes ago

Endo Pharmaceuticals and Indevus Pharmaceuticals, Inc have entered into a merger agreement under which Endo will commence a tender offer to acquire 100 percent of the outstanding shares of Indevus for approximately $370 million, or $4.50 per Indevus share, in cash, and up to an additional approximately $267 million, or $3.00 per Indevus share, in cash payable in the future upon achievement of certain regulatory and sales milestones. The transaction has been approved by the boards of directors...... (more)

Apollo inks pact with US-based insurance company Anthem Wellpoint

Pharmabiz.com (India) | 6 hours 25 minutes ago

Apollo Hospitals has signed an agreement with a US-based insurance company Anthem Blue Cross and Blue Shield a subsidiary of Anthem Wellpoint. WellPoint is one of the largest healthcare insurers in the US. As per the agreement Anthem WellPoint will initially send the employees of Serigraph Inc, a corporate client of Anthem WellPoint, to Apollo Hospitals for certain elective procedures at Delhi and Bangalore Apollo Hospitals to start with and later to all JCI accredited Apollo Hospitals. All t...... (more)

Depomed's license pact with Solvay Pharma clears HSR review

Pharmabiz.com (India) | 6 hours 26 minutes ago

Depomed, Inc announced that the previously announced product license agreement under which Solvay Pharmaceuticals will have exclusive rights for DM-1796 for the treatment of pain in the United States, Canada, Mexico and Puerto Rico, has cleared review under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. The $25 million upfront payment to Depomed under the agreement is due 60 days following the completion of the HSR review.... (more)

1 2 3 4 5 6 7 8 9 ... Next >

204 Stories | RSS Feed

Sign up for FDLI SmartBrief

Designed specifically for professionals involved in the food and drug industry, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more